Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy

被引:0
|
作者
Arndt H. Brachat
Alexei A. Grom
Nico Wulffraat
Hermine I. Brunner
Pierre Quartier
Riva Brik
Liza McCann
Huri Ozdogan
Lidia Rutkowska-Sak
Rayfel Schneider
Valeria Gerloni
Liora Harel
Maria Terreri
Kristin Houghton
Rik Joos
Daniel Kingsbury
Jorge M. Lopez-Benitez
Stephan Bek
Martin Schumacher
Marie-Anne Valentin
Hermann Gram
Ken Abrams
Alberto Martini
Daniel J. Lovell
Nanguneri R. Nirmala
Nicolino Ruperto
机构
[1] Novartis Institutes for Biomedical Research,
[2] Cincinnati Children’s Hospital Medical Center,undefined
[3] PRCSG,undefined
[4] Wilhelmina Kinderziekenhuis,undefined
[5] Department of Pediatric Immunology and Rheumatology,undefined
[6] Université Paris-Descartes,undefined
[7] IMAGINE Institute,undefined
[8] Hôpital Necker-Enfants Malades. Centre de référence national pour les Arthrites Juveniles,undefined
[9] Unité d’Immunologie,undefined
[10] Hématologie et Rhumatologie Pediatrique,undefined
[11] Rambam Medical Center,undefined
[12] Department of Pediatrics B,undefined
[13] Alder Hey Children’s NHS Foundation Trust,undefined
[14] Cerrahpasa Tip Fakultesi,undefined
[15] Ic Hastaliklari ABD,undefined
[16] Romatoloji BD,undefined
[17] Institute of Rheumatology,undefined
[18] Paediatric Clinic,undefined
[19] Hospital for Sick Children,undefined
[20] Division of Rheumatology,undefined
[21] Istituto Gaetano Pini,undefined
[22] Divisione di Reumatologia,undefined
[23] Schneider Childrens Medical Center,undefined
[24] Pediatric Rheumatology Unit,undefined
[25] Universidade Federal de São Paulo,undefined
[26] Pediatrics,undefined
[27] British Columbia Children’s Hospital,undefined
[28] Universitair Ziekenhuis Gent,undefined
[29] Centrum Voor Kinderreumatologie,undefined
[30] Randall Children’s Hospital at Legacy Emanuel,undefined
[31] Floating Hospital for Children,undefined
[32] Rheumatology NEMC 286,undefined
[33] Novartis Pharmaceuticals Corporation,undefined
[34] University of Genova and Istituto Giannina Gaslini,undefined
[35] Pediatria II-PRINTO,undefined
[36] Novartis Institutes for Biomedical Research,undefined
[37] Istituto Giannina Gaslini,undefined
[38] Pediatria II-PRINTO,undefined
关键词
Biomarkers; Canakinumab; Gene expression; Interleukin-1β; Juvenile idiopathic arthritis; SJIA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Neutrophils and monocytes in the early inflammatory cascade of systemic onset Juvenile Idiopathic Arthritis
    ter Haar, Nienke M.
    de Jager, Wilco
    Scholman, Rianne C.
    Meerding, Jenny
    Vastert, Bas
    de Roock, Sytze
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 207 - 208
  • [32] Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
    Grom, Alexei A.
    Ilowite, Norman T.
    Pascual, Virginia
    Brunner, Hermine I.
    Martini, Alberto
    Lovell, Daniel
    Ruperto, Nicolino
    Leon, Karolynn
    Lheritier, Karine
    Abrams, Ken
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (01) : 218 - 228
  • [33] Changes in Growth Hormone Receptor Gene Expression during Therapy in Children with Juvenile Idiopathic Arthritis
    Bozzola, Elena
    Pagani, Sara
    Meazza, Cristina
    Cortis, Elisabetta
    Lisini, Daniela
    Laarej, Kamilla
    Bozzola, Mauro
    HORMONE RESEARCH IN PAEDIATRICS, 2012, 77 (01): : 52 - 58
  • [34] An Exploratory Analysis of Predictors of Response from 12-Weeks of Canakinumab Therapy in Patients with Active Systemic Juvenile Idiopathic Arthritis.
    Brunner, Hermine I.
    Ruperto, Nicola
    Kone-Paut, Isabelle
    Magnusson, Bo
    Ozen, Seza
    Sztajnbok, Flavio
    Anton, Jordi
    Barash, Judith
    Berner, Reinhard
    Corona, Fabrizia
    Lheritier, Karine
    Gaillez, Corine
    Martini, Alberto
    Lovell, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S413 - S413
  • [35] Long-Term Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis
    Alexeeva, Ekaterina
    Denisova, Rina
    Dvoryakovskaya, Tatyana
    Isaeva, Ksenia
    Kriulin, Ivan
    Alshevskaya, Alina
    Moskalev, Andrey
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [36] Gene expression profile of systemic onset juvenile idiopathic arthritis blood.
    Pascual, V
    Bennett, L
    Allantaz, F
    Arce, E
    Banchereau, J
    Palucka, K
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S99 - S99
  • [37] Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China
    Zhu, Xiaona
    Weng, Ruohang
    Huang, Yanyan
    Xu, Yongbin
    Yang, Jun
    He, Tingyan
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [38] Neutrophils Gene expression profile in systemic Juvenile Idiopathic Arthritis (sJIA) patients treated successfully with Anakinra
    Omoyinmi, Ebun
    Hamaoui, Raja
    Radziszewska, Anna
    Bryant, Annette
    Zheng, Dongling
    Banerjee, Priya
    Woo, Patricia
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 437 - 437
  • [39] EARLY TREATMENT WITH ANAKINRA IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Pardeo, Manuela
    Bracaglia, Claudia
    Tulone, Anna
    Insalaco, Antonella
    Marucci, Giulia
    Nicolai, Rebecca
    Messia, Virginia
    Sacco, Emanuela
    De Benedetti, Fabrizio
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 100 - 100
  • [40] Early Treatment with Anakinra in Systemic Juvenile Idiopathic Arthritis
    Pardeo, Manuela
    Bracaglia, Claudia
    Tulone, Anna
    Insalaco, Antonella
    Marucci, Giulia
    Nicolai, Rebecca
    Messia, Virginia
    Sacco, Emanuela
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2019, 71